Renadyl(2021-06-04)
- Starting date:
- June 4, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Natural Health Products - Homeopathic Medicine
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-75799
Last updated:
2021-06-10
Summary
-
Product:
Renadyl
Reason
The affected lots contain an undeclared ingredient (inulin) and are missing risk statements on the label.
Depth of distribution
Retailers
Affected products
Renadyl
DIN, NPN, DIN-HIM
NPN 80036014
Dosage form
Capsule
Strength
Bifidobacterium longum subsp. longum 15.0 billion cfu
Lactobacillus acidophilus 15.0 billion cfu
Streptococcus salivarius subsp. thermophilus 15.0 billion cfu
Lot or serial number
5421119B,5420320A,5420720B,5420820
Companies
- Recalling Firm
-
Gelda Scientific and Industrial Development Corporation
6320 Northwest Drive
Mississauga
L4V 1J7
Ontario
CANADA
- Marketing Authorization Holder
-
Gelda Scientific and Industrial Development Corporation
6320 Northwest Drive
Mississauga
L4V 1J7
Ontario
CANADA